0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 11021 results.
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Cimzia (certolizumab) Drug is a biologic medication that belongs to the class of drugs known as TNF-alpha inhibitors. It is used to treat a variety...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Entyvio (vedolizumab) is a prescription drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Incontinence & Ostomy Care market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Highlights The global Incontinence & Ostomy Care market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
